
Happiness Biotech Group Limited HAPP
Happiness Biotech Group Limited Total Inventories | HAPP
Annual Total Inventories Happiness Biotech Group Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 K | 653 K | - | 335 K | 1.39 M | 1.79 M | 2.03 M | 1.97 M | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.03 M | 119 K | 1.18 M |
Quarterly Total Inventories Happiness Biotech Group Limited
| 2026-Q4 | 2026-Q2 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653 K | 594 K | - | 653 K | - | - | 1.39 M | 14.5 K | 335 K | - | - | - | - | - | - | - | 1.79 M | - | 2.13 M | - | 2.03 M | - | - | - | 1.97 M | - | - | - | 2.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.27 M | 14.5 K | 1.26 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biogen
BIIB
|
2.17 B | $ 252.25 | 0.62 % | $ 37 B | ||
|
Nektar Therapeutics
NKTR
|
16.1 M | $ 37.17 | -0.12 % | $ 627 M | ||
|
Novavax
NVAX
|
11.5 M | $ 9.4 | -3.14 % | $ 1.52 B | ||
|
Bristol-Myers Squibb Company
BMY
|
2.69 B | $ 61.57 | 0.15 % | $ 125 B | ||
|
Ocular Therapeutix
OCUL
|
3.56 M | $ 6.49 | -0.23 % | $ 1.22 B | ||
|
Oragenics
OGEN
|
322 K | $ 0.4 | -3.86 % | $ 863 K | ||
|
Omeros Corporation
OMER
|
1.15 M | $ 16.27 | -1.81 % | $ 1.03 B | ||
|
Outlook Therapeutics
OTLK
|
3.34 M | $ 0.51 | -1.71 % | $ 17.7 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
227 M | - | - | $ 1.62 B | ||
|
Nuvation Bio
NUVB
|
11.4 M | $ 4.5 | -1.53 % | $ 1.54 B | ||
|
Puma Biotechnology
PBYI
|
5.52 M | $ 10.85 | -1.54 % | $ 543 M | ||
|
Processa Pharmaceuticals
PCSA
|
222 K | $ 1.76 | -2.76 % | $ 2.3 M | ||
|
Blueprint Medicines Corporation
BPMC
|
13.6 M | - | - | $ 8.14 B | ||
|
Pfizer
PFE
|
10.7 B | $ 29.8 | -0.78 % | $ 169 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
170 M | - | - | $ 26.6 B | ||
|
Phathom Pharmaceuticals
PHAT
|
5.52 M | $ 5.94 | 3.48 % | $ 433 M | ||
|
Paratek Pharmaceuticals
PRTK
|
16.6 M | - | - | $ 121 M | ||
|
PTC Therapeutics
PTCT
|
79.6 M | $ 61.04 | 0.74 % | $ 4.85 B |